Logo image of PCTTU

PURECYCLE TECHNOLOGIES INC (PCTTU) Stock Fundamental Analysis

NASDAQ:PCTTU - Nasdaq - US74623V2025

12  +0.77 (+6.86%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PCTTU. PCTTU was compared to 85 industry peers in the Chemicals industry. Both the profitability and financial health of PCTTU have multiple concerns. PCTTU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year PCTTU has reported negative net income.
In the past year PCTTU has reported a negative cash flow from operations.
PCTTU had negative earnings in each of the past 5 years.
In the past 5 years PCTTU always reported negative operating cash flow.
PCTTU Yearly Net Income VS EBIT VS OCF VS FCFPCTTU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -100M -200M -300M

1.2 Ratios

With a Return On Assets value of -9.79%, PCTTU is not doing good in the industry: 83.13% of the companies in the same industry are doing better.
PCTTU's Return On Equity of -24.20% is on the low side compared to the rest of the industry. PCTTU is outperformed by 84.34% of its industry peers.
Industry RankSector Rank
ROA -9.79%
ROE -24.2%
ROIC N/A
ROA(3y)-10.43%
ROA(5y)-6.53%
ROE(3y)-20.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PCTTU Yearly ROA, ROE, ROICPCTTU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -5 -10 -15 -20

1.3 Margins

PCTTU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCTTU Yearly Profit, Operating, Gross MarginsPCTTU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, PCTTU has more shares outstanding
Compared to 1 year ago, PCTTU has a worse debt to assets ratio.
PCTTU Yearly Shares OutstandingPCTTU Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M
PCTTU Yearly Total Debt VS Total AssetsPCTTU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.32, we must say that PCTTU is in the distress zone and has some risk of bankruptcy.
PCTTU has a Altman-Z score of 1.32. This is in the lower half of the industry: PCTTU underperforms 72.29% of its industry peers.
PCTTU has a Debt/Equity ratio of 1.21. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.21, PCTTU is not doing good in the industry: 75.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACCN/A
WACCN/A
PCTTU Yearly LT Debt VS Equity VS FCFPCTTU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

PCTTU has a Current Ratio of 2.92. This indicates that PCTTU is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.92, PCTTU is in the better half of the industry, outperforming 79.52% of the companies in the same industry.
A Quick Ratio of 2.92 indicates that PCTTU has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.92, PCTTU belongs to the top of the industry, outperforming 89.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 2.92
PCTTU Yearly Current Assets VS Current LiabilitesPCTTU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

3

3. Growth

3.1 Past

The earnings per share for PCTTU have decreased strongly by -157.92% in the last year.
EPS 1Y (TTM)-157.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1900%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

PCTTU is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.60% yearly.
The Revenue is expected to grow by 490.25% on average over the next years. This is a very strong growth
EPS Next Y-156.04%
EPS Next 2Y-6.74%
EPS Next 3Y10.53%
EPS Next 5Y15.6%
Revenue Next Year2625%
Revenue Next 2Y2189.73%
Revenue Next 3Y905.64%
Revenue Next 5Y490.25%

3.3 Evolution

PCTTU Yearly Revenue VS EstimatesPCTTU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 500M 1B 1.5B
PCTTU Yearly EPS VS EstimatesPCTTU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1

0

4. Valuation

4.1 Price/Earnings Ratio

PCTTU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PCTTU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCTTU Price Earnings VS Forward Price EarningsPCTTU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCTTU Per share dataPCTTU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.74%
EPS Next 3Y10.53%

0

5. Dividend

5.1 Amount

PCTTU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PURECYCLE TECHNOLOGIES INC

NASDAQ:PCTTU (1/16/2025, 8:00:01 PM)

12

+0.77 (+6.86%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-15 2024-11-15/amc
Earnings (Next)N/A N/A
Inst Owners81.37%
Inst Owner Change0%
Ins Owners3.5%
Ins Owner ChangeN/A
Market Cap2.08B
Analysts78
Price Target16.27 (35.58%)
Short Float %0%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)77.2%
Min EPS beat(2)35.6%
Max EPS beat(2)118.8%
EPS beat(4)2
Avg EPS beat(4)-11.18%
Min EPS beat(4)-173.23%
Max EPS beat(4)118.8%
EPS beat(8)4
Avg EPS beat(8)-9.63%
EPS beat(12)5
Avg EPS beat(12)-60.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)40.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-23.99%
EPS NY rev (3m)-38.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-9.13%
Revenue NY rev (3m)-78.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.95
P/tB 4.95
EV/EBITDA N/A
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-1.43
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0
BVpS2.42
TBVpS2.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.79%
ROE -24.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-10.43%
ROA(5y)-6.53%
ROE(3y)-20.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 965.79%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.92
Quick Ratio 2.92
Altman-Z 1.32
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)4982.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-157.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1900%
EPS Next Y-156.04%
EPS Next 2Y-6.74%
EPS Next 3Y10.53%
EPS Next 5Y15.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year2625%
Revenue Next 2Y2189.73%
Revenue Next 3Y905.64%
Revenue Next 5Y490.25%
EBIT growth 1Y-40.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year72.88%
EBIT Next 3Y36.95%
EBIT Next 5Y57.01%
FCF growth 1Y29.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.94%
OCF growth 3YN/A
OCF growth 5YN/A